Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study
出版年份 2021 全文链接
标题
Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study
作者
关键词
-
出版物
Lancet Child & Adolescent Health
Volume 5, Issue 5, Pages 350-356
出版商
Elsevier BV
发表日期
2021-03-24
DOI
10.1016/s2352-4642(21)00052-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis
- (2020) L. Barss et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Solutions to improve the latent tuberculosis Cascade of Care in Ghana: a longitudinal impact assessment
- (2020) Leila Barss et al. BMC INFECTIOUS DISEASES
- Cost of delivering 12-dose isoniazid and rifapentine versus 6 months of isoniazid for tuberculosis infection in a high-burden setting
- (2020) Courtney M Yuen et al. CLINICAL INFECTIOUS DISEASES
- One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
- (2019) Susan Swindells et al. NEW ENGLAND JOURNAL OF MEDICINE
- TB Preventive Therapy for individuals exposed to drug-resistant tuberculosis: feasibility and safety of a community-based delivery of fluoroquinolone-containing preventive regimen
- (2019) Amyn A Malik et al. CLINICAL INFECTIOUS DISEASES
- Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis
- (2018) Gibril J. Njie et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection
- (2018) Christopher Pease et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Preventive therapy for latent tuberculosis infection—the promise and the challenges
- (2017) G.J. Fox et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Screening contacts of patients with extrapulmonary TB for latent TB infection
- (2017) Anna Humphreys et al. THORAX
- High prevalence of TB disease in contacts of adults with extrapulmonary TB
- (2017) Tom Wingfield et al. THORAX
- Child contact management in high tuberculosis burden countries: A mixed-methods systematic review
- (2017) Daria Szkwarko et al. PLoS One
- Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons
- (2016) Timothy R. Sterling et al. AIDS
- Initiation and completion rates for latent tuberculosis infection treatment: a systematic review
- (2016) Andreas Sandgren et al. BMC INFECTIOUS DISEASES
- The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis
- (2016) Hannah Alsdurf et al. LANCET INFECTIOUS DISEASES
- Latent tuberculous infection in the United States and Canada: who completes treatment and why?
- (2015) Y. Hirsch-Moverman et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection
- (2015) Molebogeng X Rangaka et al. LANCET
- Challenges to delivery of isoniazid preventive therapy in a cohort of children exposed to tuberculosis in Timor-Leste
- (2015) Charlotte Hall et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Treatment for Preventing Tuberculosis in Children and Adolescents
- (2015) M. Elsa Villarino et al. JAMA Pediatrics
- Prospects for Tuberculosis Elimination
- (2012) Christopher Dye et al. Annual Review of Public Health
- Contact investigation for tuberculosis: a systematic review and meta-analysis
- (2012) G. J. Fox et al. EUROPEAN RESPIRATORY JOURNAL
- Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
- (2011) Timothy R. Sterling et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now